Applied DNA Announces Closing of $2.75 Million Public Offering of Common Stock and Warrants
December 27th, 2018
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants
December 21st, 2018
Applied DNA Announces Proposed Public Offering of Common Stock and Warrants
December 19th, 2018
APDN Announces Selected Preliminary 2018 Year End, Q4 Financial Results
December 13th, 2018
Everledger to Develop CertainT®-Enhanced, Blockchain-Based Platform for Provenance Verification
December 10th, 2018
Applied DNA to Participate at Cannabis Capital Forum on December 7
December 5th, 2018
LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
December 4th, 2018
SigNature® DNA Evidence Helps to Convict Over 131 Criminals to Date
November 26th, 2018
APDN, Eurofins to Support Implementation of Leather Traceability System
November 19th, 2018
